NASDAQ:RNAZ | Profit Breakdown | Transcode Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$6.79M-$6.75M-$6.75M
2026-03-31-$17.76M-$17.55M-$17.79M
2025-12-31-$16.03M-$13.44M
2025-09-30-$4.56M-$4.86M
2025-06-30-$4.22M-$4.28M-$4.28M
2025-03-31-$3.17M-$12.09M-$12.09M
2024-12-31-$5.09M-$5.92M
2024-09-30-$2.17M-$2.32M
2024-06-30-$5.11M-$5.19M
2024-03-31-$3.29M-$3.33M
2023-12-31-$4.1M-$4.09M
2023-09-30-$5.31M-$5.3M
2023-06-30-$5.12M-$4.34M
2023-03-31-$4.89M-$4.82M
2022-12-31-$5.5M-$5.13M
2022-09-30-$4.95M-$4.29M
2022-06-30-$4.71M-$4.67M
2022-03-31-$3.48M-$3.47M
2021-12-31-$2.99M-$2.8M
2021-09-30-$2.36M-$2.33M
2021-06-30-$355,528.00$2.77M$2.77M
2021-03-31-$449,465.00-$4.49M
2020-12-31-$379,001.00-$801,531.00
2020-09-30-$239,491.00-$1.37M
2020-06-30-$91,605.00-$127,198.00-$127,198.00
2020-03-31-$41,260.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$27.98M-$34.44M-$34.66M
2024-12-31-$15.66M-$16.75M-$16.75M
2023-12-31-$19.42M-$18.55M
2022-12-31-$18.63M-$17.56M
2021-12-31-$6.15M-$6.84M
2020-12-31-$726,604.00-$2.34M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.